Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editorial staff interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Biobanking increasingly is seen as an essential tool in translating biomedical research into real improvements in healthcare. Broadly speaking, a biobank (or biorespository) is defined as a collection of tissue samples and is, potentially at least, a rich source of both genetic and clinical data.

 A relatively new field with promising expectations, biobanking presents a host of opportunities and challenges. During this week’s podcast Donat Elsener, a biobanking expert, takes a close look at these and other aspects concerning biobanks. He also talks about what kinds of institutions are developing biobanks and why they are doing so. In addition, Elsener describes the types of samples being held in biobanks and the storage limitations of those samples.

 Elsener discusses the kinds of technology and equipment that are required to establish a large biobank and gives some examples of several successful large biobanks that are up and running. 

Donat Elsener is the founder of Innoco GmbH, a Switzerland-based consulting firm. In addition, Elsenser serves as director of business development for Hamilton Storage Technologies. Biobanking and lab automation are among his fields of expertise.

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »